Bellicum Pharmaceuticals: 3Q Earnings Snapshot

November 6, 2019 GMT

HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Wednesday reported a loss of $32 million in its third quarter.

The Houston-based company said it had a loss of 68 cents per share. Losses, adjusted for non-recurring costs, were 58 cents per share.

The drug developer posted revenue of $103,000 in the period.

In the final minutes of trading on Wednesday, the company’s shares hit $1.28. A year ago, they were trading at $4.52.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLCM at https://www.zacks.com/ap/BLCM